New combo pill shows promise for diabetes control over one year
NCT ID NCT02220907
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a once-daily combination of two diabetes drugs (Teneligliptin and Canagliflozin) in 153 Japanese adults with type 2 diabetes whose blood sugar was not well controlled on Teneligliptin alone. Participants took the combo pill for 52 weeks to see if it was safe and improved blood sugar levels. The goal was better long-term disease management, not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research site
Chugoku, Japan
-
Research site
Chūbu, Japan
-
Research site
Hokkaido, Japan
-
Research site
Kanto, Japan
-
Research site
Kyushu, Japan
-
Research site
Tōhoku, Japan